Literature DB >> 19644772

Chronic administration with rotenone does not enhance MPTP neurotoxicity in C57BL/6 mice.

Eriko Aoki1, Hironori Yokoyama, Hiroki Kimoto, Ryohei Yano, Hiroyuki Kato, Tsutomu Araki.   

Abstract

Systematic administration of rotenone as one of pesticides is known to produce degeneration of nigral dopaminergic neurons and motor deficits in experimental animals. Here, we investigated to determine whether systematic administration of rotenone causes the increased susceptibility in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice. Rotenone was injected into MPTP-treated mice over a period of 4 weeks. Thereafter, we evaluated the effect of rotenone 1, 3, and 6 weeks after the cessation of treatment with rotenone. In the present study with HPLC analysis, rotenone did not enhance MPTP-induced dopaminergic neurotoxicity in mice. Furthermore, MPTP + rotenone (9 mg/kg)-treated mice exhibit a significant loss of motor activity 1 day after the cessation of treatment with rotenone, However, no significant change of motor activity was found in MPTP-treated and MPTP + rotenone (9 mg/kg)-treated animals 6 weeks after the cessation of treatment with 0.5% carboxymethyl cellulose or rotenone. Our Western blot analysis study demonstrated that the change of tyrosine hydroxylase and glial fibrillary acidic protein protein levels in MPTP-treated mice was similar than that in MPTP + rotenone-treated animals. These results suggest that rotenone did not enhance MPTP neurotoxicity in mice. Our findings suggest that rotenone is not a reliable model for PD. Thus, our findings provide further valuable information for the pathogenesis of PD for exposure to agricultural pesticides.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19644772     DOI: 10.1007/s12031-009-9220-9

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  32 in total

1.  Neuroprotection for Parkinson's disease: prospects and promises.

Authors:  C Warren Olanow; Anthony H V Schapira; Yves Agid
Journal:  Ann Neurol       Date:  2003       Impact factor: 10.422

2.  Measuring the rate of progression and estimating the preclinical period of Parkinson's disease with [18F]dopa PET.

Authors:  P K Morrish; J S Rakshi; D L Bailey; G V Sawle; D J Brooks
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-03       Impact factor: 10.154

3.  Expression of S-100 protein is related to neuronal damage in MPTP-treated mice.

Authors:  Yasuko Muramatsu; Rumiko Kurosaki; Hijiri Watanabe; Mari Michimata; Mitsunobu Matsubara; Yutaka Imai; Tsutomu Araki
Journal:  Glia       Date:  2003-05       Impact factor: 7.452

4.  Chronic systemic pesticide exposure reproduces features of Parkinson's disease.

Authors:  R Betarbet; T B Sherer; G MacKenzie; M Garcia-Osuna; A V Panov; J T Greenamyre
Journal:  Nat Neurosci       Date:  2000-12       Impact factor: 24.884

5.  Neuroprotective effect of riluzole in MPTP-treated mice.

Authors:  T Araki; T Kumagai; K Tanaka; M Matsubara; H Kato; Y Itoyama; Y Imai
Journal:  Brain Res       Date:  2001-11-09       Impact factor: 3.252

6.  Selective vulnerability of dopaminergic neurons to microtubule depolymerization.

Authors:  Yong Ren; Wenhua Liu; Houbo Jiang; Qian Jiang; Jian Feng
Journal:  J Biol Chem       Date:  2005-08-09       Impact factor: 5.157

7.  The nigrostriatal dopaminergic system as a preferential target of repeated exposures to combined paraquat and maneb: implications for Parkinson's disease.

Authors:  M Thiruchelvam; E K Richfield; R B Baggs; A W Tank; D A Cory-Slechta
Journal:  J Neurosci       Date:  2000-12-15       Impact factor: 6.167

8.  Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine in mice.

Authors:  R E Heikkila; A Hess; R C Duvoisin
Journal:  Science       Date:  1984-06-29       Impact factor: 47.728

9.  Role of reactive nitrogen and reactive oxygen species against MPTP neurotoxicity in mice.

Authors:  Hironori Yokoyama; Sho Takagi; Yu Watanabe; Hiroyuki Kato; Tsutomu Araki
Journal:  J Neural Transm (Vienna)       Date:  2008-01-31       Impact factor: 3.575

Review 10.  Modeling Parkinson's disease in rats: an evaluation of 6-OHDA lesions of the nigrostriatal pathway.

Authors:  Ronald Deumens; Arjan Blokland; Jos Prickaerts
Journal:  Exp Neurol       Date:  2002-06       Impact factor: 5.330

View more
  1 in total

1.  Role of inducible or neuronal nitric oxide synthase in neurogenesis of the dentate gyrus in aged mice.

Authors:  Minami Adachi; Manami Abe; Taeko Sasaki; Hiroyuki Kato; Jiro Kasahara; Tsutomu Araki
Journal:  Metab Brain Dis       Date:  2010-11-17       Impact factor: 3.584

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.